Filing Details

Accession Number:
0001181431-12-023621
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-11 14:46:00
Reporting Period:
2012-04-09
Filing Date:
2012-04-11
Accepted Time:
2012-04-11 13:46:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267878 W Todd Kingma C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-03-07 200 $0.00 4,146 No 5 G Indirect By Trust
Common Stock Acquisiton 2012-04-09 5,000 $35.85 19,543 No 4 M Direct
Common Stock Disposition 2012-04-09 5,000 $103.50 14,543 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect By Trust
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Disposition 2012-04-09 3,369 $0.00 3,369 $35.85
Common Stock Employee Stock Option Right to Buy Disposition 2012-04-09 1,631 $0.00 5,868 $35.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-08-25 2018-08-25 No 4 M Direct
4,237 2010-08-25 2018-08-25 No 4 M Direct
Footnotes
  1. By Trust, of which the reporting person is the Trustee.
  2. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 5, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2012.
  3. The price in column 4 is a weighted average. The prices actually received ranged from $103.11 to $103.90. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.